Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	958.83	1,105	1,274	1,506	193.46	91.63
Trading Asset Securities	190.34	75.52	0.12	3.97	-	43
Cash & Short-Term Investments	1,149	1,181	1,274	1,510	193.46	134.63
Cash Growth	-1.93%	-7.33%	-15.61%	680.49%	43.70%	205.70%
Accounts Receivable	262.69	227.37	237.35	177.37	124.68	84.94
Other Receivables	10.33	15.39	10.66	16.79	9.89	8.25
Receivables	273.02	242.76	248.01	194.16	134.57	93.19
Inventory	925.59	760.22	699.43	521.86	476.55	218.84
Prepaid Expenses	-	4.19	5.61	2.47	0.04	0.73
Other Current Assets	21.72	20.7	33.92	16.19	13.1	10.23
Total Current Assets	2,370	2,209	2,261	2,245	817.71	457.62
Property, Plant & Equipment	145.51	166.88	97.32	75.45	60.04	15.33
Other Intangible Assets	3.93	3.95	0.6	0.21	0.44	0.68
Long-Term Deferred Tax Assets	22.72	14.74	18.36	3.88	2.97	3.94
Long-Term Deferred Charges	16.54	23.74	37.58	16.81	22.13	22.59
Other Long-Term Assets	4.76	-	-	18.25	2.84	7.53
Total Assets	2,563	2,418	2,415	2,359	906.13	507.68
Accounts Payable	230.65	216.32	179.57	167.37	206.07	83.18
Accrued Expenses	19.92	31.38	36.26	30.1	18.57	22.15
Short-Term Debt	191.49	30.18	0.23	9.61	0.07	17.06
Current Portion of Leases	9.66	14.06	15.88	-	-	-
Current Income Taxes Payable	26.89	12.85	6.49	6.22	8.39	8.37
Current Unearned Revenue	37.52	36.69	29.07	20.52	14.68	11.31
Other Current Liabilities	3.9	4.28	7.47	15.25	1.78	1.35
Total Current Liabilities	520.04	345.76	274.97	249.07	249.56	143.42
Long-Term Leases	34.99	37.95	41.19	31.21	27.71	-
Long-Term Deferred Tax Liabilities	5.47	7.2	8.06	2.77	-	-
Other Long-Term Liabilities	-	-	1.27	-	-	-
Total Liabilities	560.5	390.91	325.49	283.05	277.27	143.42
Common Stock	90.88	90.88	90.88	64.92	48.69	45
Additional Paid-In Capital	1,787	1,755	1,754	1,776	483.24	321.04
Retained Earnings	331.51	289.63	252.08	242.48	96.51	-1.07
Treasury Stock	-199.98	-99.99	-	-	-	-
Comprehensive Income & Other	-6.66	-8.6	-6.96	-7.25	0.43	-0.71
Shareholders' Equity	2,002	2,027	2,090	2,076	628.86	364.26
Total Liabilities & Equity	2,563	2,418	2,415	2,359	906.13	507.68
Total Debt	236.14	82.2	57.3	40.82	27.78	17.06
Net Cash (Debt)	913.03	1,099	1,217	1,469	165.68	117.57
Net Cash Growth	-15.65%	-9.72%	-17.17%	786.71%	40.92%	522.67%
Net Cash Per Share	10.42	12.35	13.44	19.93	2.47	1.90
Filing Date Shares Outstanding	86.15	88.33	90.88	90.88	68.16	68.16
Total Common Shares Outstanding	86.15	88.33	90.88	90.88	68.16	63
Working Capital	1,849	1,863	1,986	1,996	568.15	314.2
Book Value Per Share	23.24	22.95	22.99	22.84	9.23	5.78
Tangible Book Value	1,999	2,023	2,089	2,076	628.42	363.58
Tangible Book Value Per Share	23.20	22.91	22.98	22.84	9.22	5.77
Buildings	-	85.07	16.58	16.58	16.58	8.49
Machinery	-	45.93	47.23	35.62	21.9	11.74
Construction In Progress	-	15.41	-	5.1	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.